格隆汇10月30日丨根据联交所最新权益披露资料显示,2023年10月25日,信达生物(01801.HK)获The Capital Group Companies, Inc.在场内以每股均价45.9276港元增持224.95万股,涉资约1.03亿港元。
增持后,The Capital Group Companies, Inc.最新持股数目为9832.686万股,持股比例由5.96%上升至6.10%。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.